GNH USA

Europe — EMA

Octanine (Human Coagulation Factor Ix)

GNH USA supplies Octanine (Human Coagulation Factor IX), a coagulation factor replacement therapy for hemophilia B and surgical bleeding.

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix?

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as an intravenous solution for intravenous use. It treats hemophilia B and is used in patients with factor IX deficiency. GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Coagulation Factor Ix used for?

Octanine is used in the management of bleeding disorders related to factor IX deficiency. It is indicated for: - Hemophilia B: Provides replacement of missing clotting factor to control and prevent bleeding episodes. - Perioperative management: Supplies factor IX to maintain hemostasis during and after surgery. - Trauma‑induced bleeding: Restores factor IX levels to aid clot formation in acute bleeding situations.

What are the side effects of Human Coagulation Factor Ix?

Octanine may cause a range of adverse reactions. Common Side Effects: - Headache - Fever - Nausea - Mild infusion‑site redness - Transient elevated liver enzymes - Fatigue Serious or Rare Side Effects: - Development of inhibitory antibodies against factor IX - Anaphylactic or severe hypersensitivity reactions - Thromboembolic events such as deep‑vein thrombosis - Severe hemolysis - Renal impairment - Disseminated intravascular coagulation (DIC)

What precautions apply to Human Coagulation Factor Ix?

When using Octanine, consider the following precautions: - Monitor factor IX activity levels: Adjust dosing based on laboratory results. - Assess for inhibitors: Test for anti‑factor IX antibodies before and during therapy. - Evaluate bleeding risk: Use caution in patients with a history of thrombosis. - Review concomitant anticoagulants: Adjust therapy to avoid excessive clotting or bleeding. - Pregnancy and lactation: Use only if clearly needed; weigh maternal benefits against potential fetal risk. - Store at 2‑8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix interact with?

Octanine can interact with several medicines. Major Interactions (Avoid): - Activated protein C concentrates: May reduce efficacy of factor IX. - High‑dose aspirin or other antiplatelet agents: Increases bleeding risk. - Warfarin: May potentiate anticoagulant effect and complicate monitoring. Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): May modestly increase bleeding tendency. - Heparin: Requires careful coagulation monitoring. - Antibiotics such as quinolones: Potential for altered plasma protein binding.

Frequently asked questions

What is Octanine used for?+
Octanine is a recombinant human coagulation factor IX product used to replace deficient factor IX in patients with hemophilia B, to manage bleeding episodes, support surgical procedures, and treat acute trauma‑related bleeding where factor IX levels are low.
How does Human Coagulation Factor IX work in Octanine?+
The factor IX in Octanine binds to activated factor X on platelet surfaces, forming the intrinsic tenase complex that converts prothrombin to thrombin, leading to fibrin clot formation and restoration of normal hemostasis in individuals lacking functional factor IX.
What is the usual dose of Octanine?+
Dosing of Octanine is individualized; the prescribing clinician determines the amount and frequency based on the patient’s factor IX activity level, severity of bleeding, body weight, and clinical response.
Is Octanine safe during pregnancy or breastfeeding?+
Octanine should be used during pregnancy or lactation only if clearly needed. Clinicians weigh the potential benefits for the mother against any possible risks to the fetus or infant, as safety data are limited.
How do I order Octanine from GNH USA?+
To order Octanine, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.
How does Octanine compare with other factor IX products?+
Octanine is a recombinant factor IX concentrate similar in efficacy to other licensed factor IX products. Differences may include manufacturing source, specific activity, stability profile, and approved indications, which clinicians consider when selecting therapy.
What are the storage and handling requirements for Octanine?+
Octanine must be stored at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the vial; allow the solution to reach room temperature before intravenous administration if required.
How is Octanine administered?+
Octanine is supplied as an intravenous solution and is administered by slow IV infusion under aseptic conditions, typically in a clinical setting such as a hospital or infusion centre, following the prescriber’s dosing instructions.
What are the most serious risks associated with Octanine?+
Serious risks include the development of inhibitory antibodies against factor IX, severe hypersensitivity or anaphylactic reactions, and rare thrombotic events such as deep‑vein thrombosis or disseminated intravascular coagulation.
Who should not use Octanine?+
Octanine is contraindicated in patients with known hypersensitivity to any component of the product, and it should be used with caution in individuals with a history of inhibitors, severe thrombosis, or uncontrolled hypertension.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Human Coagulation Factor Ix
Route
Intravenous Use
Manufacturer
Octapharma Benelux S.A.
Origin
EU

Related products